-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The six species that make up the genus
Brucella
infect a wide variety of animals and humans (
1
). This bacterial species is gram-negative and classified as a facultative intracellular pathogen (reviewed in ref.
2
). In the livestock industry of the United States and numerous countries throughout the world, the major economic impact of
Brucella
is its ability to induce abortions in cattle (
3
).
B. abortus
is able to infect and replicate within macrophages (
4
–
6
), trophoblasts (
7
–
9
), and a variety of other cells (
10
–
12
). It is not clearly understood how virulent strains of
B. abortus
survive in the bovine host for extended periods of time in the face of a detectable cell-mediated immunity (
3
). In order to determine the genetic basis of the virulence of
Brucella
, i.e., to replicate and live inside professional and nonprofessional phagocytic cells, it is necessary to identify virulence genes as well as characterize these genes by complementation and mutational studies. Thus, the ability to transform
Brucella
with suicide plasmids (to introduce transposons or cause allelic exchanges) or replicating plasmids (to perform complementation studies) is paramount in implementing molecular approaches to unravel the genetic basis for
Brucella
virulence determinants.
